DZP advises Global Pharma CM in an M&A transaction to acquire Neuca Group as a strategic shareholder

DZP has advised Global Pharma CM, a Polish company manufacturing dietary supplements and medical devices, and its owner on a transaction involving the acquisition of 50% of the company's shares by Neuca Group, leader on the Polish pharmaceutical wholesale distribution market.

Thanks to the transaction, our client will gain the support of a partner experienced in the pharmaceutical market, which will enable it to speed up its scheduled research work.

Our support covered comprehensive legal assistance with the transaction to both the seller and the company. The client was advised by Piotr Jackowski, Senior Associate in DZP's Capital Markets and Financial Institutions Practice, supported by Filip Lisak and Grzegorz Sprawka from the Tax Practice. The advice was supervised by Andrzej Foltyn, Head of Practice.

Global Pharma CM develops and manufactures its own products, which are sold by its business partners under their brands in over 50 countries worldwide. The company is growing rapidly and is expecting revenue of approx. PLN 28 million in 2021.

In addition to distributing pharmaceuticals, Global Pharma CM conducts research and development work in the development, testing and registration of new medical devices and dietary supplements and offers its customers a comprehensive R&D service. The sale of part of its shares will also allow the company to strengthen its operations on foreign markets.